Patient characteristics and prognostic factors in advanced treatment lines in metastatic neuroendocrine tumors

J Endocrinol Invest. 2026 Mar 31. doi: 10.1007/s40618-026-02857-9. Online ahead of print.

NO ABSTRACT

PMID:41915358 | DOI:10.1007/s40618-026-02857-9